amiloride has been researched along with Atherogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brownstein, DG; Chapman, K; Deuchar, GA; Hadoke, PWF; Kotelevtsev, YV; McLean, D; Mullins, JJ; Seckl, JR; Webb, DJ | 1 |
| Cui, GM; Liu, ZS; Peng, QS; Sun, WC; Zhang, NN; Zhao, YX | 1 |
2 other study(ies) available for amiloride and Atherogenesis
| Article | Year |
|---|---|
11β-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe-/- mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Amiloride; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cell Line; Endothelium, Vascular; Eplerenone; Gene Expression Regulation, Enzymologic; Inflammation; Male; Mice; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Sodium Channel Blockers; Spironolactone | 2011 |
Amiloride attenuates lipopolysaccharide-accelerated atherosclerosis via inhibition of NHE1-dependent endothelial cell apoptosis.
Topics: Amiloride; Animals; Apoptosis; Atherosclerosis; Calcium; Calpain; Cation Transport Proteins; Endothelial Cells; Epithelial Sodium Channel Blockers; Human Umbilical Vein Endothelial Cells; Humans; Lipopolysaccharides; Male; Mice; Proto-Oncogene Proteins c-bcl-2; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers | 2013 |